个人简介
教育背景:
1999.09 - 2003.06,山东大学药学院,药学学士
2003.09 - 2006.06,原国家医药管理局四川抗菌素工业研究所,药剂学硕士
2009.09 - 2012.06,四川大学生物治疗国家重点实验室,药剂学博士
工作经历:
2012.10 - 2013.10,香港浸会大学,博士后
2013.10 - 2015.12,中国海洋大学医药学院,讲师 / 师资博后
2015.12 - 2020.12,中国海洋大学医药学院,副教授
2021.01 - 至今,中国海洋大学医药学院,教授
研究领域
生物医用纳米载体材料的制备
靶向给药系统的构建
应用药物制剂的研究与开发
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.XueZheng, JizhenXie, XingZhang, WeitingSun, HeyangZhao, YantuanLi* and Cheng Wang*. An overview of polymeric
nanomicelles in clinical trials and on the market. Chinese Chem Lett. 32(1), 243-257, 2021.
2. Jingmin Shen, Chao Sun, Zhicheng Wang, Zhijie Chu, Chengcheng Liu, Xuelian Xu, Ming Xia, Miaoqing Zhao* and Cheng
Wang*. Sequential receptor–mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell
death and reshaping the tumor microenvironment. Int J Pharm. 601:120553.2021.
3.Xue Zheng, Chao Sun, Rilei Yu, Xin Chu, Jiahao Xu, Chengcheng Liu, Miaoqing Zhao, Xuelian Xu, Ming Xia* and Cheng Wang*. CD13-specific Ligand Facilitates Xanthatin Nanomedicine Targeting Dendritic Cells for Therapy of Refractory Allergic Rhinitis. Int J Pharm. 577:119034, 2020.
4.Mian Yu, Miaoqing Zhao, Rilei Yu,Shaochen Chu, Jiahao Xu, Ming Xia*, Cheng Wang*. Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti- tumor Effects. J Control Release. 304, 242-258, 2019
5. Jiaqi Yin,Weijian Wang,Xuelian Xu,Hongxia Li,Mengyi Cong,Xia Zhao* and Cheng Wang* Preparation, characterization and pharmacokinetics of extended-release tablets of marine polysaccharide drug. J Drug Deliv Sci Tec. 43, 353-361, 2018
6.Ying Hao, Jinrong Peng, Yaguang Zhang, Lijuan Chen, Feng Luo, Cheng Wang* and Zhiyong Qian*. Tumor Neovasculature-Targeted APRPG-PEG-PDLLA/MPEG-PDLLA Mixed Micelle Loading CombretastatinA4 for Breast Cancer Therapy.ACS Biomater Sci Eng. 4, 1986-1999 2018.
7. Hongxia Li, Yun Li, Xuelian Xu, Mengyi Cong, Jiaqi Yin and Cheng Wang*. Preparation and Characterization of Novel Pimecrolimus Nanoparticles for Therapy of Allergic Conjunctivitis. J Biomed Nanotechnol.13,1106-1114 2017.
8.Mengyi Cong, Zhongyu Wu, Xuelian Xu, Jiaqi Yin, Hongxia Li, Bo Zhuang, Cheng Wang* and Xia Zhao*. Novel Oleyl Amine-modified Polymannuronic Acid Micelle Loading Tacrolimus for Therapy of Allergic Conjunctivitis.Int J BiolMacromol. 104,862-873 2017.
9.Cheng Wang, Biao Liu, Xuelian Xu, Bo Zhuang, Hongxia Li, Jiaqi Yin, Mengyi Cong, Wei Xu* and Aiping Lu*Toward Targeted Therapy in Chemotherapy-resistant Pancreatic Cancer with A Smart Triptolide Nanomedicine. Oncotarget. 7(7). 8360-722016
10.Bo Zhuang, Liang Du, Hongxia Xu, Xuelian Xu,Cheng Wang*,Yingfang Fan, Mengyi Cong, Jiaqi Yin, Hongxia Li and Huashi Guan*. Self-assembled Micelle Loading Cabazitaxel for therapy of Lung Cancer. Int J Pharm. 499:146-155.2016.
学术兼职
国家自然科学基金委网评专家
国家药监局药物制剂技术研究及评价重点实验室学术委员
中国医药生物技术协会纳米生物技术委员会委员
国家药品监督管理局仿制药研究与评价重点实验室学术委员
山东省一致性评价技术专家委员会药物制剂组专家
青岛市药剂学会副主任委员